Search research articles
Contact Us
Filters
Showing results (81-90 of 106) with videos related to
Page
of 11
Sort By:
BMC Medicine
|
February 11, 2022
c-MET/VEGFR-2 co-localisation impacts on survival following bevacizumab therapy in epithelial ovarian cancer: an exploratory biomarker study of the phase 3 ICON7 trial
Robert D Morgan, Cristina Ferreras, Isabel Peset, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
October 17, 2021
Replication catastrophe is responsible for intrinsic PAR glycohydrolase inhibitor-sensitivity in patient-derived ovarian cancer models
Camilla Coulson-Gilmer, Robert D Morgan, Louisa Nelson, et al.
Journal of Medical Genetics
|
August 14, 2025
Homologous recombination deficiency in unselected cases of high-grade ovarian carcinoma
Robert D Morgan, George J Burghel, Joseph Shaw, et al.
American Journal of Obstetrics and Gynecology
|
February 18, 2026
Risk of ovarian cancer in women with a pathogenic or likely pathogenic variant in NBN: a systematic review and meta-analysis
Subhasheenee Ganesan, Lea Mansour, Amanda Dibden, et al.
Clinical Colorectal Cancer
|
December 13, 2025
Overall Survival for Bevacizumab Therapy in Metastatic Colorectal Cancer: An Updated Analysis of the TRAVASTIN Study
Rosie Maye Solomon, Robert D Morgan, Laura Horsley, et al.
British Journal of Cancer
|
March 9, 2022
BRCA1/2 in non-mucinous epithelial ovarian cancer: tumour with or without germline testing?
Robert D Morgan, George J Burghel, Nicola Flaum, et al.
Journal of Medical Genetics
|
January 27, 2019
Prevalence of germline pathogenic <i>BRCA1/2</i> variants in sequential epithelial ovarian cancer cases
Robert D Morgan, George J Burghel, Nicola Flaum, et al.
Cancers
|
February 11, 2023
Is Reflex Germline <i>BRCA1/2</i> Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?
Robert D Morgan, George J Burghel, Nicola Flaum, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
August 3, 2024
Extended panel testing in ovarian cancer reveals BRIP1 as the third most important predisposition gene
Robert D Morgan, George J Burghel, Nicola Flaum, et al.
NAR Cancer
|
July 17, 2024
Intrinsic PARG inhibitor sensitivity is mimicked by <i>TIMELESS</i> haploinsufficiency and rescued by nucleoside supplementation
Camilla Coulson-Gilmer, Samantha Littler, Bethany M Barnes, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 106) with videos related to
Sort By:
Page
of 11
BMC Medicine
|
February 11, 2022
c-MET/VEGFR-2 co-localisation impacts on survival following bevacizumab therapy in epithelial ovarian cancer: an exploratory biomarker study of the phase 3 ICON7 trial
Robert D Morgan, Cristina Ferreras, Isabel Peset, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
October 17, 2021
Replication catastrophe is responsible for intrinsic PAR glycohydrolase inhibitor-sensitivity in patient-derived ovarian cancer models
Camilla Coulson-Gilmer, Robert D Morgan, Louisa Nelson, et al.
Journal of Medical Genetics
|
August 14, 2025
Homologous recombination deficiency in unselected cases of high-grade ovarian carcinoma
Robert D Morgan, George J Burghel, Joseph Shaw, et al.
American Journal of Obstetrics and Gynecology
|
February 18, 2026
Risk of ovarian cancer in women with a pathogenic or likely pathogenic variant in NBN: a systematic review and meta-analysis
Subhasheenee Ganesan, Lea Mansour, Amanda Dibden, et al.
Clinical Colorectal Cancer
|
December 13, 2025
Overall Survival for Bevacizumab Therapy in Metastatic Colorectal Cancer: An Updated Analysis of the TRAVASTIN Study
Rosie Maye Solomon, Robert D Morgan, Laura Horsley, et al.
British Journal of Cancer
|
March 9, 2022
BRCA1/2 in non-mucinous epithelial ovarian cancer: tumour with or without germline testing?
Robert D Morgan, George J Burghel, Nicola Flaum, et al.
Journal of Medical Genetics
|
January 27, 2019
Prevalence of germline pathogenic <i>BRCA1/2</i> variants in sequential epithelial ovarian cancer cases
Robert D Morgan, George J Burghel, Nicola Flaum, et al.
Cancers
|
February 11, 2023
Is Reflex Germline <i>BRCA1/2</i> Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?
Robert D Morgan, George J Burghel, Nicola Flaum, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
August 3, 2024
Extended panel testing in ovarian cancer reveals BRIP1 as the third most important predisposition gene
Robert D Morgan, George J Burghel, Nicola Flaum, et al.
NAR Cancer
|
July 17, 2024
Intrinsic PARG inhibitor sensitivity is mimicked by <i>TIMELESS</i> haploinsufficiency and rescued by nucleoside supplementation
Camilla Coulson-Gilmer, Samantha Littler, Bethany M Barnes, et al.
Page
of 11